Pawan Hans divestment likely in a couple of months, officials say

The disinvestment process is in the final stages, with three financial bids received, an official said.

Yaruqhullah Khan

March 15, 2022 / 15:21 IST

Pawan Hans has the largest fleet of helicopters in India.

26 Aug, 2025 12:21

Volume

Todays L/H

The government has received three financial bids for its stake in ailing helicopter operator Pawan Hans and is likely to complete the divestment of the public sector enterprise in a couple of months, people familiar with the developments told Moneycontrol.

The privatisation of Pawan Hans is likely to fetch Rs 300-350 crore, the people said.

This is the government’s fifth attempt to privatise the company, which has a fleet of over 40 helicopters and almost 900 employees, including 450 who are on the permanent rolls.

“We are working with the transaction advisor and are in the final stages of completing the divestment process of Pawan Hans and will look to complete the process in the next couple of months,” a senior government official said. The official declined to identify the bidders.

The Employees’ Union of Pawan Hans, Global Vectra Helicorp and Heligo Charters were widely expected to bid for the company. None of the potential buyers confirmed to Moneycontrol if they had submitted financial bids.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show